SCHEMBL10288307

SCHEMBL10288307

COc1ccc2ccc(Cc3c(C(=O)O)sc(N4CCOCC4)c3C#N)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.47
CLK1 P49759 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
KDM4E B2RXH2 6/20 0.40
ALDH1A1 P00352 3/20 0.40
WNT3A P56704 1/20 0.40
TSHR P16473 1/20 0.38
CASP1 P29466 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PTGS1 P23219 1/20 0.38
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
LRRK2 Q5S007 1/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
THRB P10828 1/20 0.37
GRIA2 P42262 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10288158 0.98 PIK3CA (0.48) PIK3CACLK1RXFP1KDM4EALDH1A1
SCHEMBL10006318 0.90 PIK3CA (0.51) PIK3CAKDM4EALDH1A1HSD17B10MAPT
SCHEMBL10298669 0.90 PIK3CA (0.53) PIK3CAKDM4EALDH1A1TSHRMAPT
SCHEMBL10288327 0.87 PIK3CA (0.48) PIK3CARXFP1KDM4EALDH1A1HSD17B10
SCHEMBL10298714 0.86 PIK3CA (0.49) PIK3CARXFP1KDM4EALDH1A1HSD17B10
SCHEMBL10298673 0.85 PIK3CA (0.52) PIK3CARXFP1MAPTSMN1; SMN2LMNA
SCHEMBL624522 0.84 PIK3CA (0.47) PIK3CAGRIA2GRIA4FNTAFNTB
SCHEMBL10298682 0.84 PIK3CA (0.52) PIK3CARXFP1KDM4EHSD17B10MAPT
SCHEMBL10298541 0.84 KDM4E (0.40) KDM4EALDH1A1WNT3ATSHRCASP1
SCHEMBL10308548 0.83 PIK3CA (0.52) PIK3CACLK1RXFP1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175563-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-20150175593-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARM INC (US) 2015-06-25 US disclosed
US-8796268-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-8796271-B2 Heteroaryls and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-05 US disclosed
US-20120178723-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-12 US disclosed
US-20120172345-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-05 US disclosed
WO-2012021696-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120172345-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885CLK1 2715/4885RXFP1 2451/4885
US-20150175563-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885CLK1 2715/4885RXFP1 2451/4885
US-20120178723-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885CLK1 3193/4885RXFP1 2530/4885
US-20150175593-A1 HETEROARYLS AND USES THEREOF PIK3R1, PIK3R2, PIK3R3 PIK3CA 5/4885CLK1 3193/4885RXFP1 2530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.